H.C. Wainwright Reiterates Buy Rating on BioStem Tech (BSEM)

August 24, 2026 6:51 AM EDT Send to a Friend
H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating and $7.00 price target on BioStem Tech (NASDAQ: BSEM).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login